0
Gain Therapeutics, Inc. Banner Image

Gain Therapeutics, Inc.

  • Ticker GANX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Gain Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Bethesda, Maryland
Gain Therapeutics, Inc. is a biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate GT-02287, in development for the treatment of GBA1 Parkinson’s disease, has completed IND-enabling GLP toxicology studies. Clinical evaluation of GT-02287 is expected to begin this year.
Gain Therapeutics, Inc.

Most Recent Annual Report

Gain Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Gain Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!